Organisation paid for research Program year 2025 Source: CMS Open Payments

TX Dgstv Disease Consultants

Neither a doctor nor a teaching hospital

Research payments

$1,855,058

992 payments

Through program year 2025, TX Dgstv Disease Consultants is reported as receiving $1,855,058 in research payments, across 992 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$419,619	167
2024	Research	$920,426	609
2023	Research	$365,980	201
2022	Research	$13,196	3
2020	Research	$76,325	4
2019	Research	$59,512	8

Breakdown

Who paid Research payments · program years 2019–2025

Janssen Research & Development, LLC $1,855,058 992 payments

Studies the money was for Research payments · program years 2019–2025

78934804Uco2001 $736,363 520 payments
78934804Crd2001 $495,047 274 payments
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis (DUET-UC) $337,589 117 payments
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease $132,809 14 payments
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease (DUET-CD) $82,030 50 payments
Cnto1959crd3007 $26,400 5 payments
Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis $25,172 2 payments
Cnto1959crd3004 $19,648 10 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.